Sichun Zhou

811 total citations
20 papers, 596 citations indexed

About

Sichun Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sichun Zhou has authored 20 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Sichun Zhou's work include Metabolism, Diabetes, and Cancer (7 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and RNA modifications and cancer (4 papers). Sichun Zhou is often cited by papers focused on Metabolism, Diabetes, and Cancer (7 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and RNA modifications and cancer (4 papers). Sichun Zhou collaborates with scholars based in China and Germany. Sichun Zhou's co-authors include Xiaoping Yang, Jun Deng, Mei Peng, Ting Tao, Caimei He, Yanjun Huang, Di Xiao, Qiongli Su, Zhiren Wang and Kwame Oteng Darko and has published in prestigious journals such as Journal of Cellular Physiology, Medicine and Cell Death and Disease.

In The Last Decade

Sichun Zhou

20 papers receiving 590 citations

Peers

Sichun Zhou
Jun Deng China
Jiao Li China
Bing Dai China
Jun Deng China
Sichun Zhou
Citations per year, relative to Sichun Zhou Sichun Zhou (= 1×) peers Jun Deng

Countries citing papers authored by Sichun Zhou

Since Specialization
Citations

This map shows the geographic impact of Sichun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sichun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sichun Zhou more than expected).

Fields of papers citing papers by Sichun Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sichun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sichun Zhou. The network helps show where Sichun Zhou may publish in the future.

Co-authorship network of co-authors of Sichun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Sichun Zhou. A scholar is included among the top collaborators of Sichun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sichun Zhou. Sichun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Sichun, Duo Li, Di Xiao, et al.. (2022). Inhibition of PKM2 Enhances Sensitivity of Olaparib to Ovarian Cancer Cells and Induces DNA Damage. International Journal of Biological Sciences. 18(4). 1555–1568. 28 indexed citations
2.
Xiao, Di, Xin Hu, Mei Peng, et al.. (2022). Inhibitory role of proguanil on the growth of bladder cancer via enhancing EGFR degradation and inhibiting its downstream signaling pathway to induce autophagy. Cell Death and Disease. 13(5). 499–499. 12 indexed citations
3.
Huang, Yanjun, Caimei He, Sichun Zhou, et al.. (2022). The beneficial effects of alpha‐tocopherol on intestinal function and the expression of tight junction proteins in differentiated segments of the intestine in piglets. Food Science & Nutrition. 11(2). 677–687. 4 indexed citations
4.
Wang, Wei, Di Xiao, Sichun Zhou, et al.. (2022). Synthesis, Anticancer Activities, and Mechanism of N-heptyl-containingBiguanide Derivatives. Medicinal Chemistry. 18(8). 895–902. 2 indexed citations
5.
Zhou, Sichun, Mei Qin, Jing Tang, et al.. (2021). Phenformin and ataxia‐telangiectasia mutated inhibitors synergistically co‐suppress liver cancer cell growth by damaging mitochondria. FEBS Open Bio. 11(5). 1440–1451. 5 indexed citations
6.
Tang, Mei, Dongliang Chen, Meiyuan Huang, et al.. (2020). Methylation of the ataxia telangiectasia mutated gene (ATM) promoter as a radiotherapy outcome biomarker in patients with hepatocellular carcinoma. Medicine. 99(4). e18823–e18823. 12 indexed citations
7.
He, Caimei, Xin Hu, Di Xiao, et al.. (2020). Vitamin A prevents lipopolysaccharide‐induced injury on tight junctions in mice. Food Science & Nutrition. 8(4). 1942–1948. 16 indexed citations
8.
Peng, Mei, Jun Deng, Sichun Zhou, et al.. (2019). Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth. Frontiers in Pharmacology. 10. 1159–1159. 19 indexed citations
9.
Peng, Mei, Jun Deng, Sichun Zhou, et al.. (2019). <p>The role of Clusterin in cancer metastasis</p>. Cancer Management and Research. Volume 11. 2405–2414. 39 indexed citations
10.
Xiao, Di, Zhicheng Lü, Zhiren Wang, et al.. (2019). Synthesis, biological evaluation and anti-proliferative mechanism of fluorine-containing proguanil derivatives. Bioorganic & Medicinal Chemistry. 28(2). 115258–115258. 9 indexed citations
11.
Qu, Lihua, Chao Chen, Wei He, et al.. (2019). Glycyrrhizic acid ameliorates LPS-induced acute lung injury by regulating autophagy through the PI3K/AKT/mTOR pathway.. PubMed. 11(4). 2042–2055. 87 indexed citations
12.
He, Caimei, Jun Deng, Xin Hu, et al.. (2019). Vitamin A inhibits the action of LPS on the intestinal epithelial barrier function and tight junction proteins. Food & Function. 10(2). 1235–1242. 145 indexed citations
13.
Su, Qiongli, Jun Deng, Sichun Zhou, et al.. (2019). The role of pyruvate kinase M2 in anticancer therapeutic treatments (Review). Oncology Letters. 18(6). 5663–5672. 29 indexed citations
14.
Zhou, Sichun, Mengru Cao, Zhiren Wang, et al.. (2019). Anticancer properties of novel pyrazole‐containing biguanide derivatives with activating the adenosine monophosphate‐activated protein kinase signaling pathway. Archiv der Pharmazie. 352(9). e1900075–e1900075. 15 indexed citations
15.
Tao, Ting, Shiyuan Wu, Zheng Sun, et al.. (2019). The molecular mechanisms of LncRNA-correlated PKM2 in cancer metabolism. Bioscience Reports. 39(11). 10 indexed citations
16.
Deng, Jun, Mei Peng, Zhiren Wang, et al.. (2018). Novel application of metformin combined with targeted drugs on anticancer treatment. Cancer Science. 110(1). 23–30. 41 indexed citations
17.
Su, Qiongli, Ting Tao, Lei Tang, et al.. (2018). Down‐regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer. Journal of Cellular and Molecular Medicine. 22(5). 2774–2790. 27 indexed citations
18.
Tao, Ting, Qiongli Su, Jun Deng, et al.. (2018). Down‐regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP‐1c axis. Journal of Cellular Physiology. 234(3). 3088–3104. 68 indexed citations
19.
Huang, Yanjun, Sichun Zhou, Caimei He, et al.. (2018). Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways. Cancer Communications. 38(1). 50–50. 26 indexed citations
20.
Ge, Liangquan, et al.. (1997). Proposed Correction and Influence of Drilling Fluids in X‐Ray Fluorescence Logging. X-Ray Spectrometry. 26(5). 303–308. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026